Publisher： Bentham Science Publishers
E-ISSN： 1875-533x|15|14|1350-1375
ISSN： 0929-8673
Source： Current Medicinal Chemistry, Vol.15, Iss.14, 2008-06, pp. : 1350-1375
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
DNA methyltransferases (DNMTs) are important regulators of gene transcription and their roles in carcinogenesis have been a topic of considerable interest in the last few years. Diverse classes of chemical compounds including nucleotide analogues, adenosine analogues, aminobenzoic derivatives, polyphenols, hydrazines, phthalides, disulfides and antisenses are being discovered and evaluated as DNMT inhibitors targeting DNA hypermethylation. Among them, 5-Azacytidine 5 and Decitabine 6 were launched recently. Several other compounds are under clinical trials. Some of these compounds were discovered from structure-based drug design. These compounds exert their DNA methylation inhibitory by different mechanisms. This review will present a brief account of various DNA methyltransferases and their biological functions, with focus on actuality of design and synthesis of various inhibitors of DNA hypermethylation as anticancer drugs.
Related content
Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery
Current Pharmaceutical Design, Vol. 16, Iss. 16, 2010-06 ,pp. :
Access to resources
Recommend
Current Targets for Anticancer Drug Discovery
Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. :